MEDPACE HOLDINGS INC (MEDP) Stock Fundamental Analysis
NASDAQ:MEDP • US58506Q1094
428.03 USD
+11.99 (+2.88%)
At close: Feb 13, 2026
428.03 USD
0 (0%)
After Hours: 2/13/2026, 8:23:52 PM
Taking everything into account, MEDP scores 7 out of 10 in our fundamental rating. MEDP was compared to 58 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues. MEDP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes MEDP very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year MEDP was profitable.
- MEDP had a positive operating cash flow in the past year.
- MEDP had positive earnings in each of the past 5 years.
- Each year in the past 5 years MEDP had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 22.84%, MEDP belongs to the top of the industry, outperforming 98.28% of the companies in the same industry.
- MEDP's Return On Equity of 98.27% is amongst the best of the industry. MEDP outperforms 100.00% of its industry peers.
- MEDP's Return On Invested Capital of 71.19% is amongst the best of the industry. MEDP outperforms 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MEDP is significantly above the industry average of 12.43%.
- The last Return On Invested Capital (71.19%) for MEDP is above the 3 year average (49.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROIC | 71.19% |
ROA(3y)19.71%
ROA(5y)17.64%
ROE(3y)65.94%
ROE(5y)56.06%
ROIC(3y)49.2%
ROIC(5y)40.37%
1.3 Margins
- MEDP has a Profit Margin of 17.83%. This is amongst the best in the industry. MEDP outperforms 91.38% of its industry peers.
- MEDP's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 21.14%, MEDP belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
- MEDP's Operating Margin has improved in the last couple of years.
- MEDP has a worse Gross Margin (30.06%) than 74.14% of its industry peers.
- MEDP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% |
OM growth 3Y3.46%
OM growth 5Y3.23%
PM growth 3Y2.01%
PM growth 5Y2.64%
GM growth 3Y0.5%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
- MEDP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- MEDP has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, MEDP has less shares outstanding
- There is no outstanding debt for MEDP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- MEDP has an Altman-Z score of 6.40. This indicates that MEDP is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 6.40, MEDP belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
- There is no outstanding debt for MEDP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.4 |
ROIC/WACC6.58
WACC10.82%
2.3 Liquidity
- A Current Ratio of 0.74 indicates that MEDP may have some problems paying its short term obligations.
- With a Current ratio value of 0.74, MEDP is not doing good in the industry: 94.83% of the companies in the same industry are doing better.
- MEDP has a Quick Ratio of 0.74. This is a bad value and indicates that MEDP is not financially healthy enough and could expect problems in meeting its short term obligations.
- MEDP has a worse Quick ratio (0.74) than 93.10% of its industry peers.
- The current and quick ratio evaluation for MEDP is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
- MEDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.14%, which is quite impressive.
- The Earnings Per Share has been growing by 31.30% on average over the past years. This is a very strong growth
- Looking at the last year, MEDP shows a quite strong growth in Revenue. The Revenue has grown by 19.97% in the last year.
- Measured over the past years, MEDP shows a very strong growth in Revenue. The Revenue has been growing by 22.27% on average per year.
EPS 1Y (TTM)21.14%
EPS 3Y27.86%
EPS 5Y31.3%
EPS Q2Q%27.25%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y20.12%
Revenue growth 5Y22.27%
Sales Q2Q%32.03%
3.2 Future
- The Earnings Per Share is expected to grow by 10.29% on average over the next years. This is quite good.
- Based on estimates for the next years, MEDP will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y9.87%
EPS Next 2Y10.52%
EPS Next 3Y10.19%
EPS Next 5Y10.29%
Revenue Next Year11.99%
Revenue Next 2Y10.2%
Revenue Next 3Y11.36%
Revenue Next 5Y10.47%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 27.98, MEDP can be considered very expensive at the moment.
- MEDP's Price/Earnings ratio is a bit cheaper when compared to the industry. MEDP is cheaper than 63.79% of the companies in the same industry.
- MEDP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.68.
- With a Price/Forward Earnings ratio of 25.46, MEDP can be considered very expensive at the moment.
- MEDP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MEDP is cheaper than 67.24% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.06. MEDP is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 25.46 |
4.2 Price Multiples
- MEDP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MEDP is cheaper than 67.24% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of MEDP indicates a rather cheap valuation: MEDP is cheaper than 87.93% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.68 | ||
| EV/EBITDA | 20.53 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MEDP does not grow enough to justify the current Price/Earnings ratio.
- MEDP has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.83
PEG (5Y)0.89
EPS Next 2Y10.52%
EPS Next 3Y10.19%
5. Dividend
5.1 Amount
- No dividends for MEDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
428.03
+11.99 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-09 2026-02-09/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners87.1%
Inst Owner Change-91.28%
Ins Owners0.44%
Ins Owner Change-6.05%
Market Cap12.06B
Revenue(TTM)2.53B
Net Income(TTM)451.12M
Analysts52.22
Price Target557.47 (30.24%)
Short Float %6.04%
Short Ratio5.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.54%
Min EPS beat(2)7.52%
Max EPS beat(2)9.56%
EPS beat(4)4
Avg EPS beat(4)9.37%
Min EPS beat(4)2.57%
Max EPS beat(4)17.84%
EPS beat(8)8
Avg EPS beat(8)12.36%
EPS beat(12)11
Avg EPS beat(12)11.35%
EPS beat(16)15
Avg EPS beat(16)14.34%
Revenue beat(2)2
Avg Revenue beat(2)0.84%
Min Revenue beat(2)0.75%
Max Revenue beat(2)0.93%
Revenue beat(4)4
Avg Revenue beat(4)3.88%
Min Revenue beat(4)0.75%
Max Revenue beat(4)9.78%
Revenue beat(8)4
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)1.31%
Revenue beat(16)10
Avg Revenue beat(16)1.28%
PT rev (1m)1.27%
PT rev (3m)7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.98 | ||
| Fwd PE | 25.46 | ||
| P/S | 4.77 | ||
| P/FCF | 17.68 | ||
| P/OCF | 16.91 | ||
| P/B | 26.27 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.53 |
EPS(TTM)15.3
EY3.57%
EPS(NY)16.81
Fwd EY3.93%
FCF(TTM)24.21
FCFY5.66%
OCF(TTM)25.32
OCFY5.92%
SpS89.82
BVpS16.3
TBVpS-8.4
PEG (NY)2.83
PEG (5Y)0.89
Graham Number74.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROCE | 84.68% | ||
| ROIC | 71.19% | ||
| ROICexc | 333.94% | ||
| ROICexgc | N/A | ||
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% | ||
| FCFM | 26.95% |
ROA(3y)19.71%
ROA(5y)17.64%
ROE(3y)65.94%
ROE(5y)56.06%
ROIC(3y)49.2%
ROIC(5y)40.37%
ROICexc(3y)169.04%
ROICexc(5y)114.84%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)58.52%
ROCE(5y)48.87%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y101.11%
ROICexc growth 5Y74.12%
OM growth 3Y3.46%
OM growth 5Y3.23%
PM growth 3Y2.01%
PM growth 5Y2.64%
GM growth 3Y0.5%
GM growth 5Y-0.03%
F-Score7
Asset Turnover1.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.49% | ||
| Cap/Sales | 1.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 126.67% | ||
| Profit Quality | 151.15% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 6.4 |
F-Score7
WACC10.82%
ROIC/WACC6.58
Cap/Depr(3y)125.21%
Cap/Depr(5y)134.9%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.98%
Profit Quality(3y)144.35%
Profit Quality(5y)141.17%
High Growth Momentum
Growth
EPS 1Y (TTM)21.14%
EPS 3Y27.86%
EPS 5Y31.3%
EPS Q2Q%27.25%
EPS Next Y9.87%
EPS Next 2Y10.52%
EPS Next 3Y10.19%
EPS Next 5Y10.29%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y20.12%
Revenue growth 5Y22.27%
Sales Q2Q%32.03%
Revenue Next Year11.99%
Revenue Next 2Y10.2%
Revenue Next 3Y11.36%
Revenue Next 5Y10.47%
EBIT growth 1Y19.71%
EBIT growth 3Y24.28%
EBIT growth 5Y26.22%
EBIT Next Year13.88%
EBIT Next 3Y12.83%
EBIT Next 5Y12.46%
FCF growth 1Y19.15%
FCF growth 3Y24.75%
FCF growth 5Y24.56%
OCF growth 1Y17.15%
OCF growth 3Y22.49%
OCF growth 5Y22.49%
MEDPACE HOLDINGS INC / MEDP FAQ
What is the fundamental rating for MEDP stock?
ChartMill assigns a fundamental rating of 7 / 10 to MEDP.
Can you provide the valuation status for MEDPACE HOLDINGS INC?
ChartMill assigns a valuation rating of 5 / 10 to MEDPACE HOLDINGS INC (MEDP). This can be considered as Fairly Valued.
What is the profitability of MEDP stock?
MEDPACE HOLDINGS INC (MEDP) has a profitability rating of 9 / 10.
What are the PE and PB ratios of MEDPACE HOLDINGS INC (MEDP) stock?
The Price/Earnings (PE) ratio for MEDPACE HOLDINGS INC (MEDP) is 27.98 and the Price/Book (PB) ratio is 26.27.
How financially healthy is MEDPACE HOLDINGS INC?
The financial health rating of MEDPACE HOLDINGS INC (MEDP) is 8 / 10.